Stress Management for Couples Undergoing In Vitro Fertilization (IVF)

November 5, 2015 updated by: Amit Sood

Stress Management for Couples With Infertility Undergoing In Vitro Fertilization (IVF)

The investigators are trying to determine stress management strategies in couples undergoing In Vitro Fertilization (IVF).

Study Overview

Detailed Description

The investigators are trying to determine two different stress management techniques in couples undergoing IVF. One arm will be randomized to learning these techniques by themselves by watching and following instructions on a digital video disc (DVD). The other arm will have an in-person class that will teach the couples different stress reduction techniques.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Rochester, Minnesota, United States, 55905
        • Mayo Clinic in Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Women with clinical infertility, either primary or secondary, who are recommended for IVF for the first time as part of their treatment for infertility
  • Women with a partner, and both are willing to provide consent for study participation as a couple
  • Couples that can be reached by telephone for follow-up

Exclusion Criteria:

  • Women less than 18 years of age
  • Women equal or greater than 40 years of age
  • Women with a history of recurrent pregnancy loss
  • History of current or recent psychotic episode within past 6 months for either the woman or her partner
  • Couples needing a interpreter for their clinical encounter

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stress Management & Resiliency Training
The couples in this group will attend the SMART in-person training class at the beginning of the study and will be taught a structured relaxation program.
The couples in this group will attend the SMART in-person training class at the beginning of the study and will be taught a structured relaxation program.
Active Comparator: Stress Management DVD
The couples in this group will receive a Mayo Clinic Stress Management DVD.
The couples in this group will receive a Mayo Clinic Stress Management DVD.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Scores from questionnaires from baseline to 6 and then 12 weeks
Time Frame: Baseline, 6 and 12 weeks after randomization
Primary outcome measure will be comparison of pre- and post-stress reduction treatment questionnaire scale scores.
Baseline, 6 and 12 weeks after randomization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Pregnancy rate
Time Frame: 12 months after randomization
Clinical pregnancy rate: which is defined as seeing a gestational sac in the uterus with a fetal pole that has a heart beat.
12 months after randomization

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical or biochemical miscarriage
Time Frame: 12 months after randomization
Miscarriage will be defined as a biochemical or clinical miscarriage. A biochemical miscarriage will include a rise and then subsequent fall in beta human chorionic gonadotrophin (BhCG) to less than 5 IU/L. A clinical miscarriage will be defined as vaginal bleeding with passage of products of conception recognized as products of conception by histopathology.
12 months after randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Amit Sood, MD, Mayo Clinic
  • Study Chair: Zaraq Khan, MBBS, Mayo Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Actual)

September 1, 2015

Study Completion (Actual)

September 1, 2015

Study Registration Dates

First Submitted

October 18, 2012

First Submitted That Met QC Criteria

October 23, 2012

First Posted (Estimate)

October 26, 2012

Study Record Updates

Last Update Posted (Estimate)

November 6, 2015

Last Update Submitted That Met QC Criteria

November 5, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 12-007272

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Stress Management & Resiliency Training

Subscribe